Lineage Cell Therapeutics, Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
Lineage Cell Therapeutics, Inc. (LCTX) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $8.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-10
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.00K, a 99.51% decline year-over-year.
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.00K, a 99.31% decline year-over-year.
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $5.00K, a 88.37% decline year-over-year.
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $8.00K, a 98.91% decline from fiscal 2016.
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $736.00K, a 60.70% increase from fiscal 2015.
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $458.00K, a 21.81% increase from fiscal 2014.
- Lineage Cell Therapeutics, Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $376.00K, a 36.23% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $3.00K derived: sum of 2 quarters · filed 2018-03-15 | $3.00K derived: sum of 3 quarters · filed 2018-03-15 | $8.00K 10-K · filed 2018-03-15 | ||||
| 2017-09-30 | $1.00K 10-Q · filed 2017-11-09 | $1.00K derived: sum of 2 quarters · filed 2017-11-09 | $6.00K 10-Q · filed 2017-11-09 | $411.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | $5.00K 10-Q · filed 2017-08-09 | $410.00K derived: sum of 3 quarters · filed 2018-05-10 | $554.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-03-31 | $5.00K 10-Q · filed 2018-05-10 | $410.00K derived: sum of 2 quarters · filed 2018-05-10 | $554.00K derived: sum of 3 quarters · filed 2018-05-10 | $686.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $549.00K derived: sum of 2 quarters · filed 2018-03-15 | $681.00K derived: sum of 3 quarters · filed 2018-03-15 | $736.00K 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $144.00K 10-Q · filed 2017-11-09 | $276.00K derived: sum of 2 quarters · filed 2017-11-09 | $331.00K 10-Q · filed 2017-11-09 | $449.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $132.00K 10-Q · filed 2017-08-09 | $176.00K 10-Q · filed 2017-08-09 | $305.00K derived: sum of 3 quarters · filed 2018-03-15 | $445.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $43.00K 10-Q · filed 2017-05-10 | $173.00K derived: sum of 2 quarters · filed 2018-03-15 | $313.00K derived: sum of 3 quarters · filed 2018-03-15 | $411.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $270.00K derived: sum of 2 quarters · filed 2018-03-15 | $368.00K derived: sum of 3 quarters · filed 2018-03-15 | $458.00K 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $140.00K 10-Q · filed 2016-11-04 | $238.00K derived: sum of 2 quarters · filed 2016-11-04 | $328.00K 10-Q · filed 2016-11-04 | $404.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $98.00K 10-Q · filed 2016-08-09 | $188.00K 10-Q · filed 2016-08-09 | $264.00K derived: sum of 3 quarters · filed 2017-03-16 | $374.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $90.00K 10-Q · filed 2016-05-10 | $89.92K 10-Q · filed 2015-05-08 | $166.00K derived: sum of 2 quarters · filed 2017-03-16 | $276.00K derived: sum of 3 quarters · filed 2017-03-16 | $367.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $186.00K derived: sum of 2 quarters · filed 2017-03-16 | $277.00K derived: sum of 3 quarters · filed 2017-03-16 | $376.00K 10-K · filed 2017-03-16 | $375.76K 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $110.00K 10-Q · filed 2015-11-09 | $110.56K 10-Q · filed 2014-11-07 | $201.00K derived: sum of 2 quarters · filed 2015-11-09 | $300.00K 10-Q · filed 2015-11-09 | $299.62K 10-Q · filed 2014-11-07 | $361.31K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $91.00K 10-Q · filed 2015-08-10 | $90.48K 10-Q · filed 2014-08-11 | $189.00K 10-Q · filed 2015-08-10 | $189.07K 10-Q · filed 2014-08-11 | $251.31K derived: sum of 3 quarters · filed 2016-03-15 | $341.58K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $98.59K 10-Q · filed 2015-05-08 | $160.31K derived: sum of 2 quarters · filed 2016-03-15 | $250.58K derived: sum of 3 quarters · filed 2016-03-15 | $307.86K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $61.72K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $152.00K derived: sum of 2 quarters · filed 2016-03-15 | $209.28K derived: sum of 3 quarters · filed 2016-03-15 | $276.00K 10-K · filed 2016-03-15 | $276.06K 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $90.27K 10-Q · filed 2014-11-07 | $147.55K derived: sum of 2 quarters · filed 2014-11-07 | $214.28K 10-Q · filed 2014-11-07 | $248.09K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $57.28K 10-Q · filed 2014-08-11 | $124.00K 10-Q · filed 2014-08-11 | $157.81K derived: sum of 3 quarters · filed 2015-03-11 | $248.16K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | $66.72K 10-Q · filed 2014-05-12 | $100.53K derived: sum of 2 quarters · filed 2015-03-11 | $190.88K derived: sum of 3 quarters · filed 2015-03-11 | $250.13K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | $33.81K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $124.15K derived: sum of 2 quarters · filed 2015-03-11 | $183.41K derived: sum of 3 quarters · filed 2015-03-11 | $251.19K 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | $90.34K 10-Q · filed 2013-11-12 | $149.59K derived: sum of 2 quarters · filed 2013-11-12 | $217.38K 10-Q · filed 2013-11-12 | $457.42K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $59.25K 10-Q · filed 2013-08-09 | $127.04K 10-Q · filed 2013-08-09 | $367.08K derived: sum of 3 quarters · filed 2014-03-17 | $551.29K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $67.53K 10-Q · filed 2013-05-10 | $47.28K 10-Q · filed 2012-05-10 | $307.82K derived: sum of 2 quarters · filed 2014-03-17 | $492.04K derived: sum of 3 quarters · filed 2014-03-17 | $611.56K derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2011-12-31 | $240.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $424.51K derived: sum of 2 quarters · filed 2014-03-17 | $544.03K derived: sum of 3 quarters · filed 2014-03-17 | $646.27K 10-K · filed 2014-03-17 | $566.94K 10-K · filed 2012-03-14 | |||
| 2011-09-30 | $184.22K 10-Q · filed 2012-11-09 | $165.72K 10-Q · filed 2011-11-08 | $303.74K derived: sum of 2 quarters · filed 2012-11-09 | $405.98K 10-Q · filed 2012-11-09 | $347.22K 10-Q · filed 2011-11-08 | $404.51K derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2011-06-30 | $119.52K 10-Q · filed 2012-08-09 | $94.72K 10-Q · filed 2011-08-09 | $208.61K 10-Q · filed 2012-08-09 | $183.81K 10-Q · filed 2011-08-09 | $220.29K derived: sum of 3 quarters · filed 2013-03-18 | $328.81K derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2011-03-31 | $88.45K 10-Q · filed 2012-05-10 | $100.77K derived: sum of 2 quarters · filed 2013-03-18 | $209.29K derived: sum of 3 quarters · filed 2013-03-18 | $220.97K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $12.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $120.84K derived: sum of 2 quarters · filed 2013-03-18 | $132.52K derived: sum of 3 quarters · filed 2013-03-18 | $133.27K 10-K · filed 2013-03-18 | $105.61K 10-K · filed 2012-03-14 | |||
| 2010-09-30 | $108.52K 10-Q · filed 2011-11-08 | $120.20K derived: sum of 2 quarters · filed 2011-11-08 | $120.95K 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $11.67K 10-Q · filed 2011-08-09 | $13.48K 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $5.59K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |